Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rab geranylgeranyltransferase subunit alpha (RABGGTA) is the alpha subunit of the heterodimeric Rab geranylgeranyltransferase enzyme (also called protein geranylgeranyltransferase type II). It catalyzes the transfer of geranylgeranyl moieties from geranylgeranyl diphosphate to the C-terminal cysteine residues of Rab GTPase proteins—a post-translational modification necessary for their membrane association and role in vesicular trafficking. Unlike other prenyltransferases, Rab GGTase relies on the Rab escort protein (REP) for substrate recognition and specificity. RABGGTA is essential for correct Rab protein localization and function across diverse cell types, and loss-of-function mutations can cause defects in intracellular trafficking, especially notable in blood platelets. In vitro, it can be inhibited by drugs such as nitrogen-containing bisphosphonates, though therapeutic applications are limited by essential housekeeping functions of the enzyme[1][5][6][2][9].
Inhibition of Rab GGTase activity, leading to impaired Rab protein prenylation and membrane localization[1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rab geranylgeranyltransferase subunit alpha (RABGGTA).